Presentations now available with permissions. More to follow..
Session 1: BSBMT Abstract Prize Competition
– Over-expression of CXCR4 targets donor T cells to tumor niches and enhances graft-versus-lymphoma – Dr Ben Carpenter, Institute of Cancer Studies
High engraftment rates following second allogeneic transplants for graft failure result in good outcomes – Dr Robert Lown, Anthony Nolan
Experience of FLT3 inhibitors in relapsed AML post allogeneic haematopoietic stem cell transplantation – Dr Harpreet Kaur, Royal Hallamshire Hospital
Engine tuning in T cells: a strategy to improve cancer immunotherapy – Dr Mathias Zech, UCL Medical School
The impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune-reconstitution and clinical outcome – Dr Robert Chiesa, GOSH
State-of-the-art: Update on cord transplanation – Prof Vanderson Rocha, University of Oxford
Session 2: BMT for Non-Malignant Disorders in Adults
– Autoimmune disease – Dr John Snowden, Sheffield Teaching Hospitals
Aplastic Anaemia – Prof Judith Marsh, King’s College London
Session 3: BSBMT Open Meeting
President’s Report – Dr Charles Crawley on behalf of Prof Gordon Cook
CTC Report – Dr Andy Peniket
Treasurer’s Report – Dr Charles Crawley
Data Registry Report – Mrs Keiren Kirkland
State-of-the-art: Low dose IL-2 in chronic GVHD – Prof Jerome Ritz, Dana-Farber Cancer Institute Boston, USA
Session 4: BMT for Non-Malignant Disorders in Paediatric Practice
– Metabolic disorder – Dr Jaap Boelens, University Medical Center, Utrecht
Primary immunodeficiencies – Dr Paul Veys, GOSH
– Haemoglobinopathies – Dr Josu de la Fuente, Imperial College London
